Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 88951-89000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07108400
Efficacy of a Combination of Ultrasound-guided Intra-articular Injections of Hyaluronic Acid, High-power Laser Therapy and Rehabilitation on Functioning in Patients Affected by Hip Osteoarthritis.
NARecruiting
57 participants
Started: Mar 17, 2022 · Completed: Dec 12, 2025
1 condition1 sponsor2 locations
NCT04936009
Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)
NARecruiting
60 participants
Started: Mar 17, 2022 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
PHASE4Recruiting
280 participants
Started: Mar 17, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors7 locations
NCT04837339
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
NARecruiting
900 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2037
4 conditions1 sponsor1 location
NCT05076643
Biomarkers, TCM Body Constitution, Dietary Pattern and Psychological Factors in Predicting Depression
N/ARecruiting
397 participants
Started: Mar 17, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05157971
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
PHASE1Recruiting
24 participants
Started: Mar 17, 2022 · Completed: Feb 7, 2026
2 conditions2 sponsors1 location
NCT05364749
Selective CT for Anticoagulated Head Injured Patients
N/ARecruiting
4,000 participants
Started: Mar 17, 2022 · Completed: Sep 30, 2027
4 conditions2 sponsors7 locations
NCT05130177
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
PHASE2Recruiting
26 participants
Started: Mar 16, 2022 · Completed: Jan 31, 2031
1 condition2 sponsors1 location
NCT05489068
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
NARecruiting
150 participants
Started: Mar 16, 2022 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT05145283
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
PHASE2Recruiting
250 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors2 locations
NCT05176795
Host-microbiota-environment Interactions
N/ARecruiting
60 participants
Started: Mar 16, 2022 · Completed: Sep 30, 2026
3 conditions2 sponsors1 location
NCT05156437
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
PHASE4Enrolling by invitation
20 participants
Started: Mar 16, 2022 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05308927
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
N/AEnrolling by invitation
221 participants
Started: Mar 16, 2022 · Completed: Mar 17, 2028
1 condition1 sponsor3 locations
NCT05300581
Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids
NARecruiting
50 participants
Started: Mar 16, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05315141
Multicenter Cohort Study of AAV in Hunan of China
N/ARecruiting
500 participants
Started: Mar 16, 2022 · Completed: Mar 16, 2027
1 condition5 sponsors1 location
NCT05856383
Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
N/ARecruiting
100 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05121168
Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy
PHASE4Enrolling by invitation
50 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT05333068
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NAActive, not recruiting
1,222 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors49 locations
NCT03960099
Pictographs for Preventing Wrong-Patient Errors in NICUs
NARecruiting
6,250 participants
Started: Mar 16, 2022 · Completed: Jun 30, 2028
2 conditions6 sponsors4 locations
NCT07196189
Effects of Fecal Microbiota Transplantation
N/ARecruiting
84 participants
Started: Mar 16, 2022 · Completed: Apr 16, 2027
1 condition1 sponsor1 location
NCT05367635
A Study of SKB315 in Patients With Advanced Solid Tumors
PHASE1Recruiting
206 participants
Started: Mar 16, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05423860
Phase I Human Analytics (HALO) Study
N/ARecruiting
2,000 participants
Started: Mar 16, 2022 · Completed: Mar 31, 2037
4 conditions2 sponsors1 location
NCT05698576
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
NARecruiting
20 participants
Started: Mar 16, 2022 · Completed: Jan 30, 2033
9 conditions1 sponsor1 location
NCT05148494
TES RCT Fleet Enema vs Oral Mechanical Bowel Prep
PHASE4Recruiting
66 participants
Started: Mar 16, 2022 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT05606315
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
PHASE4Recruiting
285 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors2 locations
NCT05296304
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
PHASE1Recruiting
20 participants
Started: Mar 16, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05494060
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
PHASE2Recruiting
80 participants
Started: Mar 16, 2022 · Completed: Feb 28, 2027
7 conditions2 sponsors1 location
NCT05279963
EA for BPS: an RCT and Study for Central Mechanism
NARecruiting
84 participants
Started: Mar 16, 2022 · Completed: Jan 23, 2025
1 condition1 sponsor1 location
NCT05332054
Long-Term Follow-up Study
N/AEnrolling by invitation
150 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2041
10 conditions1 sponsor30 locations
NCT05722990
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam
N/ARecruiting
150 participants
Started: Mar 16, 2022 · Completed: Dec 31, 2025
2 conditions5 sponsors1 location
NCT05008926
The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients
PHASE3Recruiting
370 participants
Started: Mar 15, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor11 locations
NCT05228340
Flexor Tenotomy and Ulcer Recurrence
NARecruiting
66 participants
Started: Mar 15, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05017740
PICSI RCT in Couples With a Previous Poor Fertilisation Cycle in IVF
NAActive, not recruiting
47 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05586724
Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy
PHASE3Recruiting
520 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05188014
Exercise and the Menstrual Cycle in Type 1 Diabetes
NARecruiting
15 participants
Started: Mar 15, 2022 · Completed: Aug 30, 2026
1 condition2 sponsors1 location
NCT05240131
A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).
PHASE1/PHASE2Active, not recruiting
88 participants
Started: Mar 15, 2022 · Completed: Nov 1, 2025
1 condition3 sponsors5 locations
NCT05226858
Transesophageal Echocardiography To Diagnose Blunt Traumatic Aortic Injury Traumatic Aortic Injury
N/ARecruiting
56 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2025
1 condition6 sponsors6 locations
NCT05307731
Fingolimod for Type 2 Diabetes Mellitus
PHASE4Recruiting
40 participants
Started: Mar 15, 2022 · Completed: Mar 15, 2026
1 condition1 sponsor1 location
NCT05774548
LA PrEP Impact and Cost-effectiveness (TEAMS)
NARecruiting
10,720 participants
Started: Mar 15, 2022 · Completed: Dec 30, 2026
1 condition2 sponsors12 locations
NCT05338931
Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2Recruiting
82 participants
Started: Mar 15, 2022 · Completed: Sep 15, 2030
1 condition1 sponsor1 location
NCT05261672
Regional Midazolam in Quadratus Lumborum Block
NARecruiting
60 participants
Started: Mar 15, 2022 · Completed: Jan 20, 2024
1 condition1 sponsor1 location
NCT05277688
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
PHASE3Recruiting
340 participants
Started: Mar 15, 2022 · Completed: Dec 30, 2027
1 condition1 sponsor2 locations
NCT06403891
The Effect of a Comprehensive Rehabilitation Program Using Robotic Walking and Functional Electrical Stimulation Technologies on Balance and Walking in Children With Cerebral Palsy
N/ARecruiting
30 participants
Started: Mar 15, 2022 · Completed: May 15, 2024
1 condition1 sponsor1 location
NCT05331443
Effects of Ramadan Fasting on Endothelial Function
N/AEnrolling by invitation
250 participants
Started: Mar 15, 2022 · Completed: Jul 15, 2024
2 conditions1 sponsor1 location
NCT05799209
Floatation-REST in Methamphetamine Use Disorder: A Pilot Study
NARecruiting
100 participants
Started: Mar 15, 2022 · Completed: Aug 1, 2024
1 condition1 sponsor1 location
NCT05662189
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
NARecruiting
70 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05260125
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients
PHASE4Recruiting
50 participants
Started: Mar 15, 2022 · Completed: Mar 30, 2025
2 conditions1 sponsor1 location
NCT05248646
Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
PHASE3Active, not recruiting
530 participants
Started: Mar 15, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor297 locations
NCT04890639
Acute Intermittent Hypoxia in Traumatic Brain Injury
NARecruiting
16 participants
Started: Mar 15, 2022 · Completed: Nov 1, 2024
1 condition2 sponsors1 location
NCT05648019
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
PHASE2Recruiting
40 participants
Started: Mar 15, 2022 · Completed: Dec 31, 2026
6 conditions2 sponsors2 locations